Guangwu Guo

Guangwu Guo serves as the Associate Director of Quantitative Biology at Vor Bio since June 2022, focusing on data visualization and analysis for anti-CD33 CAR T drug products, including preparation for IND applications and addressing FDA inquiries. Prior experience includes roles as a Senior Scientist in Computational Biology at TCR² Therapeutics Inc., where Guangwu established a computational platform for NGS data analysis, and as a Senior Bioinformatician at WuXi NextCODE, managing NGS workflows on the AWS cloud. As a Postdoctoral Research Fellow at both Dana-Farber Cancer Institute and the Broad Institute, Guangwu developed innovative tools and conducted genomic studies to advance cancer research. Guangwu holds a Ph.D. in Bioinformatics from the Chinese Academy of Sciences and a Bachelor's degree in Bioengineering from China Agricultural University.